BCM
LUMO

Bluefin Capital Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bluefin Capital Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,007
Closed -$1.32M – 1082
2014
Q2 		$1.4M Buy
+6,007
New +$1.22M 0.06% 255

Other funds holding LUMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Bluefin Capital Management's LUMO Position: Q3 2014 in Review

Bluefin Capital Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2014, closing a stake of 6,007 shares — an estimated $1.32M sold.

Bluefin Capital Management first reported a position in LUMO in Q2 2014 and held it in 1 quarter. The position peaked at $1.4M in Q2 2014. 92 funds tracked by Wall St. Rank hold LUMO as of Q3 2014.

  • Bluefin Capital Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Bluefin Capital Management sold 6,007 Lumos Pharma, Inc. Common Stock shares in Q3 2014, an estimated $1.32M.
  • Bluefin Capital Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2014 and held it in 1 quarter.
  • Bluefin Capital Management's Lumos Pharma, Inc. Common Stock position peaked at $1.4M in Q2 2014.
  • 92 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2014.

Based on Bluefin Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.